PDF) P728 Changes in the use of biologics in the treatment of IBD patients over time. Results from a comprehensive Norwegian registry study
Figure 1 | Economic Impact of Non-Medical Switching from Originator Biologics to Biosimilars: A Systematic Literature Review | SpringerLink
nowości pediatryczne na 9. Kongresie eCCO 2014 w Kopenhadze
Home - ECCO - European Confederation of Conservator-Restorers' Organisation
N029 Patients experience of advice received on the use of topical therapies in inflammatory bowel disease (IBD) N030 Real benefi
Inflammatory Bowel Diseases 2014 Bella Center Copenhagen, Denmark EACCME applied Register online at - ppt download
PDF) Results of the 4th scientific workshop of the ECCO (I): Pathophysiology of intestinal fibrosis in IBD | Giovanni Latella and Giorgos Bamias - Academia.edu
Untitled
ECCO News
Home
ECCO » ECCO Meetings
Results of the 4th scientific workshop of the ECCO (I): Pathophysiology of intestinal fibrosis in IBD - [PDF Document]
Home
PDF) P775 Evolution of inflammatory bowel disease research from a bird's eye perspective: A text-mining analysis of publication trends and topics
PDF) P698 Persistence, clinical effectiveness and safety of vedolizumab in the post-marketing real clinical practice in Italy: a double-centre, 2-year experience in Crohn's disease and ulcerative colitis patients
10th Congress of ECCO
Home
N-ECCO survey results of nursing practice in caring for patients with Crohn's disease or ulcerative colitis in Europe
Current cv2016 (2)
European Crohn's and Colitis Organisation Topical Review on Complementary Medicine and Psychotherapy in Inflammatory Bowel Dis
PDF) P374 Non-alcoholic fatty liver disease in inflammatory bowel disease: Prevalence and risk factors
PDF) P743 What information is available on the internet and social media for faecal microbiota transplantation?
PDF) ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment